Haleon plc Files 6-K on Director/PDMR Shareholding

TL;DR

**Haleon filed a 6-K about insider share changes, watch for details on who bought/sold.**

AI Summary

Haleon plc, a consumer healthcare company, filed a 6-K on March 24, 2026, reporting a 'DIRECTOR/PDMR SHAREHOLDING' change. This filing indicates that an insider, likely a director or person discharging managerial responsibilities (PDMR), has either bought or sold shares. This matters to investors because insider trading activity can signal management's confidence (or lack thereof) in the company's future prospects, potentially influencing stock price.

Why It Matters

Insider shareholding changes can provide clues about how those closest to the company view its value and future, which can be a significant factor for investors.

Risk Assessment

Risk Level: medium — The filing itself is low risk, but the underlying insider trading activity it reports can carry medium risk depending on the nature and size of the transaction.

Analyst Insight

A smart investor would look for a more detailed announcement or subsequent filings from Haleon plc that specify the nature, size, and parties involved in the 'DIRECTOR/PDMR SHAREHOLDING' change to assess its potential impact.

Key Players & Entities

• Haleon plc (company) — the filer of the 6-K
• DIRECTOR/PDMR (person) — an insider whose shareholding changed

FAQ

Filing Documents

• a9483x.htm (6-K) — 102KB
• a9483x000.jpg (GRAPHIC) — 3KB
• 0001654954-26-002658.txt ( ) — 108KB

From the Filing

SHAREHOLDING a9483x UNITED STATES   SECURITIES AND EXCHANGE COMMISSION   Washington, D.C. 20549     FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of March 2026   Commission File Number: 001-41411   Haleon plc (Translation of registrant’s name into English)   Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY (Address of principal executive offices)     Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:     Form 20-F ☒   Form 40-F ☐       EXHIBIT INDEX   Exhibit Number Description 99.1 24 March 2026 - “Director/PDMR Shareholding”   99.1   ​ Haleon plc :  Director/PDMR Shareholding   ​   24 March 2026:   Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by a Person Discharging Managerial Responsibilities ("PDMR").   This notification sets out the details of the vesting of Haleon share awards over ordinary shares made to a PDMR in March 2023 under the Haleon Performance Share Plan and   Deferred Annual Bonus Plan   and the subsequent sale of ordinary shares to meet tax liabilities.   On 23 March 2026, Brian McNamara, Chief Executive Officer, received the vesting of awards of Haleon ordinary shares under the Haleon Performance Share Plan and Deferred Annual Bonus Plan. Vesting under both plans included dividends accrued.   The award under the Performance Share Plan was conditional on continued employment and on the satisfaction of the performance conditions over the performance period ended on 31 December 2025 approved by the Remuneration Committee, which (after tax on the gross award) must be retained until the shareholding requirement is met, and in any event for Executive Directors two years after receipt.     Performance targets and levels of achievement are disclosed in the 2025 Annual Report and 20-F.  The awards are subject to malus and clawback provisions.   1      Details of the issuer or emission allowance market participant   a)     Name of the entity    Haleon plc  b)     LEI     549300PSB3WWEODCUP19  2      Reason for the notification      a)     Position/status       Chief Executive Officer b)     Initial notification /Amendment to prior notifications   Initial Notification  3      Details of the person discharging managerial responsibilities / person closely associated   ("PCA") a) PDMR/PCA PDMR   b)     Name    Brian McNamara 4      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted      a)     Description of Instrument   Share       Identification code   GB00BMX86B70       b)     Nature of the transaction       Acquisition of Ordinary Shares in respect of the Haleon plc Performance Share Plan.   c)     Currency, Price(s) and Volume(s)                 Price(s)  Volume(s)          Nil 1,497,695.24             d)     Aggregated information         - Aggregated volume  N/A     - Price        e)     Date of the transaction     23 March 2026 f)     Place of the transaction     Outside a trading venue   4      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted      a)     Description of Instrument   Share       Identification code   GB00BMX86B70       b)     Nature of the transaction     &#

View Full Filing

View this 6-K filing on SEC EDGAR